FIBROUS DYSPLASIA OF BONE
Clinical trials for FIBROUS DYSPLASIA OF BONE explained in plain language.
Never miss a new study
Get alerted when new FIBROUS DYSPLASIA OF BONE trials appear
Sign up with your email to follow new studies for FIBROUS DYSPLASIA OF BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for brittle bones: drug boosts phosphate in rare bone disorder
Disease control CompletedThis study tested a drug called burosumab in 12 people with fibrous dysplasia, a condition that weakens bones and often causes low blood phosphate. Participants injected the drug at home once or twice a month for 48 weeks. The main goal was to see if the drug could bring phosphat…
Matched conditions: FIBROUS DYSPLASIA OF BONE
Phase: PHASE2 • Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Disease control
Last updated May 26, 2026 07:56 UTC
-
New hope for rare bone disease pain?
Symptom relief CompletedThis study tested a drug called tocilizumab for people with fibrous dysplasia of bone who still had pain after standard treatment. The drug blocks a protein linked to bone damage. Nineteen adults participated in this small, early-stage trial to see if the drug could reduce bone p…
Matched conditions: FIBROUS DYSPLASIA OF BONE
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated May 26, 2026 07:55 UTC
-
Tiny molecules may explain mysterious bone disease differences
Knowledge-focused CompletedThis study looked at 24 adults with fibrous dysplasia, a rare bone disease that causes pain, fractures, and deformities. Researchers wanted to find out if small molecules called microRNAs in the blood and bone tissue are linked to how severe the disease is. The goal was to better…
Matched conditions: FIBROUS DYSPLASIA OF BONE
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC